SRI SRI TATTVA is voluntarily recalling approximately 1,100 units of Ojasvita Chocomalt because the product contains soy lecithin, which is not declared on the ingredient label. The recall involves 7oz (200g) paper pouches and bottles distributed to retail stores in several states. Consumers who have purchased the affected product are urged to return it to the place of purchase for a full refund.
People who have an allergy or severe sensitivity to soy run the risk of a serious or life-threatening allergic reaction if they consume these products. To date, no incidents or injuries have been reported in connection with this recall.
You have 2 options:
Distributed 25 packages per case. FDA Recall #H-0505-2025.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.